Ashton Ritter

Trastuzumab and pertuzumab in circulating tumor DNA ERBB2-amplified HER2-positive refractory cholangiocarcinoma

P. Kasi, F. Shahjehan, B. Yarlagadda, 2019, npj Precision Oncology.

Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma

Y. Kusne, J., M., 2021 .

A Care Process Model to Deliver 177Lu-Dotatate Peptide Receptor Radionuclide Therapy for Patients With Neuroendocrine Tumors

P. Kasi, Akash Sharma, F. Shahjehan, 2019, Front. Oncol..

Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma Treated with Combined Modality Treatment Including Surgical Resection: A Pilot Study

M. Wallace, M. Raimondo, T. Woodward, 2018, Journal of pancreatic cancer.

Dramatic response to modified docetaxel, cisplatin, and fluorouracil chemotherapy after immunotherapy in a patient with refractory metastatic anal cancer

P. Kasi, F. Shahjehan, Ashton Ritter, 2019, Clinical case reports.

Feasibility of circulating tumor DNA testing in hepatocellular carcinoma.

M. Borad, P. Kasi, K. Mody, 2019, Journal of gastrointestinal oncology.

Circulating tumor DNA (ctDNA) based testing and actionable findings in patients with advanced and metastatic pancreatic adenocarcinoma.

M. Borad, T. Bekaii-Saab, P. Kasi, 2021, The oncologist.